Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang-Yu Liu

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Cancer Communications (London, England)|January 4, 2025
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST studyLi Chen, Wen-Ya Wu, Fei Liang, et al.
Plos One|December 16, 2014
ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapyJian-Wei Li, Miao Mo, Ke-da Yu, et al.
Oncotarget|June 18, 2015
Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patientsLi Zhang, Zhao-Zhi Yang, Xing-Xing Chen, et al.
Frontiers in Oncology|September 16, 2021
Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving SurgeryFei-Lin Qu, Rui Mao, Zhe-Bin Liu, et al.
Annals of Surgical Oncology|February 27, 2026
Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical StudyFei-Lin Qu, Jing-Yi Cheng, Shu-Hao Jiang, et al.
The Breast Journal|September 22, 2011
Adjuvant therapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and 5-fluorouracilJun-Jie Li, Gen-Hong Di, Li-Chen Tang, et al.
Medicine|November 10, 2016
Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patientsNai-Si Huang, Meng-Ying Liu, Jia-Jian Chen, et al.
International Journal of Surgery (London, England)|May 3, 2023
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic studySi-Yu Wu, Jian-Wei Li, Yu-Jie Wang, et al.
Breast Cancer Research and Treatment|September 4, 2012
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogramJia-ying Chen, Jia-jian Chen, Ben-long Yang, et al.
Breast Cancer Research and Treatment|June 20, 2008
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patientsWen-Jin Yin, Jin-Song Lu, Gen-Hong Di, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Cancer Communications (London, England)|January 4, 2025
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST studyLi Chen, Wen-Ya Wu, Fei Liang, et al.
Plos One|December 16, 2014
ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapyJian-Wei Li, Miao Mo, Ke-da Yu, et al.
Oncotarget|June 18, 2015
Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patientsLi Zhang, Zhao-Zhi Yang, Xing-Xing Chen, et al.
Frontiers in Oncology|September 16, 2021
Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving SurgeryFei-Lin Qu, Rui Mao, Zhe-Bin Liu, et al.
Annals of Surgical Oncology|February 27, 2026
Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical StudyFei-Lin Qu, Jing-Yi Cheng, Shu-Hao Jiang, et al.
The Breast Journal|September 22, 2011
Adjuvant therapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and 5-fluorouracilJun-Jie Li, Gen-Hong Di, Li-Chen Tang, et al.
Medicine|November 10, 2016
Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patientsNai-Si Huang, Meng-Ying Liu, Jia-Jian Chen, et al.
International Journal of Surgery (London, England)|May 3, 2023
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic studySi-Yu Wu, Jian-Wei Li, Yu-Jie Wang, et al.
Breast Cancer Research and Treatment|September 4, 2012
Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogramJia-ying Chen, Jia-jian Chen, Ben-long Yang, et al.
Breast Cancer Research and Treatment|June 20, 2008
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patientsWen-Jin Yin, Jin-Song Lu, Gen-Hong Di, et al.
Pageof 12